Brief: Intelgenx Partners With Gensco Pharma To Market RIZAPORT In The U.S.
12/12/2018 13:14
Dec 12 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX PARTNERS WITH GENSCO® PHARMA TO MARKET RIZAPORT®
IN
THE UNITED STATES
* INTELGENX TECHNOLOGIES - UNDER AGREEMENT, GENSCO HAS BEEN
GRANTED EXCLUSIVE RIGHT TO COMMERCIALIZE INTELGENX RIZAPORT
PRODUCT IN U.S.
Source text for Eikon: ID:nGNX2DwfzS
Further company coverage: IGX.V
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA